• Search
  • Advanced Search
Korean Journal of Nephrology 2002;21(2):185-189.
논평 : 말기 신부전 환자에서 투여 경로에 따른 유전자 재조합 인 에리스로포이에틴(rHuEPO)의 효과 -효과와 경제적 측면- (Route of Administration of rHuEPO to Patients with End Stage Renal Diseases - Efficacy and Economic Considerations -)
강종명 ( Kang Jong Myeong )
TOOLS
METRICS Graph View
  • 351 View
  • 10 Download
Related articles
ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
#301, (Miseung Bldg.) 23, Apgujenog-ro 30-gil, Gangnam-gu, Seoul 06022, Korea
Tel: +82-2-3486-8736    Fax: +82-2-3486-8737    E-mail: registry@ksn.or.kr                

Copyright © 2024 by The Korean Society of Nephrology.

Developed in M2PI

Close layer